ArticleMolecular and clinical oncology2024

Inflammation‑based prognostic markers in patients with advanced or recurrent gastric cancer treated with nivolumab: Tokushukai REAl‑world Data project 02 (TREAD 02).

Rai Shimoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.